Drug intelligence / Profile preview

Medterra Daily Relief CBD Oil Tincture

Development stage
Unknown
Lead developer
Medterra
Modality
Small Molecules
Administration
Oral, Sublingual
01

Overview

Medterra Daily Relief CBD Oil Tincture is a consumer wellness product containing 99%+ pure isolated cannabidiol (CBD) derived from hemp. Developed by Medterra, the product is formulated with organic medium-chain triglyceride (MCT) oil as a carrier and is guaranteed to be THC-free. It is intended for oral or sublingual administration to support the endocannabinoid system, aiming to provide daily relief from discomfort, reduce stress, promote relaxation, and improve sleep quality. As a dietary supplement rather than a pharmaceutical drug, it is marketed for general wellness and a balanced lifestyle, interacting with the body's endocannabinoid receptors to maintain homeostasis.

Brand names
Medterra Daily Relief CBD Oil TinctureDaily Relief CBD Isolate Oil
Other names
Medterra CBD OilMedterra CBD TinctureDaily Relief CBD Oil
02

Targets

TRPV1 (Transient receptor potential cation channel subfamily V member 1)GPR55 (G protein-coupled receptor 55)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))PPARG (Peroxisome proliferator-activated receptor gamma)CNR2 (Cannabinoid receptor type 2)

Beyond the preview

Go deeper on Medterra Daily Relief CBD Oil Tincture.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medterra Daily Relief CBD Oil Tincture.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call